上海市同济医院2011-2014年口服降糖药物使用情况分析

本文对上海市同济医院2011—2014年口服降糖药物（OHAs）的用药金额、用药频度、日用药金额等进行统计分析，为临床合理用药提供参考。4年来上海市同济医院OHAs品种全面，使用金额呈上升趋势，但OHAs占降糖药使用金额比例、OHAs占全部用药金额比例均处于微降趋势。a-糖苷酶抑制剂、磺脲类、双胍类4年来稳居销售金额排名1~3位；DDDs排序中，磺脲类、双胍类、a-糖苷酶抑制剂稳居1~3位。二甲双胍位列单品种DDDs排序的首位。上海市同济医院2011—2014年OHAs的临床使用基本合理，药物种类全面。

Utilization of oral hypoglycemic agents in Tongji hospital of Shanghai during 2011-2014

The utilization of oral hypoglycemic agents (OHAs) in Shanghai Tongji Hospital during 2011-2014 was statistically analyzed in respect of consumption sum, DDDs, and DDC so as to provide references for clinical medication. There were various categories of OHAs in our hospital. The consumption sum of OHAs showed an upward trend, yet the proportion of the consumption sum of OHAs in the consumption sum of hypoglycemic agents and the total drug consumption sum showed a downward trend. The top 3 of OHAs were a-glycosidase inhibitors, sulfonylureas and biguanides in the list of consumption and sulfonylureas, biguanides and a-glycosidase inhibitors in the list of DDDs, respectively. Metformin occupied the ifrst place in the list of DDDs. The use of OHAs is basically rational with various categories of OHAs.